Workflow
信澳医药健康混合A
icon
Search documents
A股不断破局 信达澳亚主动权益类基金现实力
Cai Fu Zai Xian· 2025-08-20 02:11
Core Insights - The A-share market is experiencing a rebound, with the Shanghai Composite Index reaching historical highs, boosting investor confidence and leading to a resurgence in public funds [1] - Active equity funds, particularly those managed by Xinda Australia Fund, have shown remarkable performance, creating sustained value growth for investors [1][2] Fund Performance - Xinda Australia Fund's products, including Xinda Craftsmanship Return Mixed A, Xinda Preferred Life Mixed A, Xinda Medical Health Mixed A, and Xinda Performance Driven Mixed A, have achieved net value growth rates of 70.82%, 57.40%, 57.46%, and 51.72% respectively in 2025 [1] - According to Haitong Securities, these funds ranked in the top 10% of their category as of June 30, 2025, with respective rankings of 138/3751, 214/3751, 338/3751, and 162/3751 [1] - Over the past five years, Xinda Australia's equity products have yielded a return of 17.86%, ranking 47 out of 137 in the market, while the seven-year return reached 149.24%, placing second out of 115 [2] Investment Strategy - Xinda Australia Fund emphasizes a dual-driven approach of "talent + technology," utilizing intelligent analysis tools and multi-factor quantitative models to enhance decision-making efficiency [2] - The firm has actively responded to industry fee reforms, prioritizing investor benefits and reinforcing market trust [2] - The fund's investment strategy focuses on long-term value creation aligned with national industrial upgrading directions, aiming to provide sustainable returns for investors [2] Fund Manager Profiles - Xinda Craftsmanship Return Mixed Fund is managed by Zhang Mingye, who has a background in industry analysis and has been with Xinda Australia since 2020 [3] - Xinda Preferred Life Mixed Fund is managed by Yang Ke, who has experience in consumer industry research and has been with Xinda Australia since 2015 [4] - Xinda Medical Health Mixed Fund is currently managed by Li Diandian, who has a background in biochemistry and has been with Xinda Australia since 2020 [6] - Xinda Performance Driven Mixed Fund is managed by Liu Xiaoming, who has extensive experience in equity investment and joined Xinda Australia in 2021 [6]
信达澳亚7只权益产品集体斩获五星评级
Cai Fu Zai Xian· 2025-07-14 07:49
Core Insights - The latest fund rating report from Tianxiang Investment Advisory highlights that seven equity products from Xinda Australia Fund Management Co., Ltd. achieved the highest five-star rating due to their long-term stable performance and excellent risk control capabilities [1] - The competition for ratings was intense, with only less than 6% of the 723 actively managed equity funds receiving a five-year five-star rating, and less than 11% and 4% of the 2796 mixed equity funds receiving three-year and five-year five-star ratings, respectively [1] Performance Metrics - Xinda Australia's products, including Xinao Advanced Manufacturing Stock A, Xinao Star Yi Mixed A/C, Xinao New Energy Selected Mixed A, Xinao Medical Health Mixed A, and Xinao Prosperity Preferred Mixed A, all received three-year five-star ratings [1] - Xinao Core Technology Mixed A stood out by receiving both three-year and five-year five-star ratings, showcasing the company's strong performance across multiple products [1] - According to Guotai Junan Securities, as of June 30, 2025, Xinao Advanced Manufacturing Stock A ranked in the top 1/5 percentile of active stock open-end funds over the past five years, placing 66th out of 376 products [1] Investment Strategy - Xinda Australia has been enhancing its investment research system, aiming to establish a benchmark for all categories of equity investment and continuously optimizing its active management capabilities [1] - The company has gathered a team of experienced fund managers with over ten years of practical experience, who are adept at deep research to uncover valuable investment targets, thereby building a solid moat for long-term equity investments [1] Industry Context - The five-star rating has become the "gold standard" for measuring the comprehensive strength of products as the regulatory framework for fund rating systems continues to improve [1] - The collective achievement of seven products by Xinda Australia not only demonstrates the company's "group combat" advantage in equity investment but also sends a positive signal to the market that fundamental research and long-term value investing remain core paths to achieving excess returns in volatile markets [1]